DefinePK hosts the largest index of Pakistani journals, research articles, news headlines, and videos. It also offers chapter-level book search.
Title: Hyperbaric Oxygen: A Lifesaver During COVID-19?
Authors: Maria Shahzadi, Muhammad Bilal
Journal: Pakistan Armed Forces Medical Journal (PAFMJ)
Publisher: Army Medical College, Rawalpindi.
Country: Pakistan
Year: 2022
Volume: 72
Issue: 1
Language: English
DOI: 10.51253/pafmj.v72i1.7269
Keywords: COVID 19Hyperbaric Oxygen TherapyHBOT
Coronavirus (COVID-19) has become a worldwide pandemic after its emergence in late December 2019. The virus has evolved through mutations such as alpha, beta, gamma, delta, and epsilon variants. The one becoming variant, becomes precarious. COVID virus spiked a surge in hospitalizations and equipment utilization, as well as a scarcity of critical care resources. The precautionary measures, such as the use of masks and hand sanitizers, are advised to contain the virus.
To explore the potential therapeutic use of hyperbaric oxygen (HBO) treatment for COVID-19, particularly in advanced stages and for progressive hypoxemia.
This is a letter to the editor, discussing existing research and potential applications of hyperbaric oxygen therapy (HBOT) for COVID-19. It references several studies to support its claims.
graph TD;
A["Review of existing literature on HBOT and COVID-19"] --> B["Discussion of HBOT mechanisms and potential benefits"];
B --> C["Identification of specific applications for COVID-19"];
C --> D["Consideration of concerns and contraindications"];
D --> E["Conclusion on the potential role of HBOT in COVID-19 treatment"];
The text discusses the mechanism by which HBOT might benefit COVID-19 patients, focusing on its ability to deliver higher concentrations of oxygen to tissues, which could counteract the lung damage caused by the virus. It also acknowledges concerns about attributing improvements solely to HBOT and notes contraindications for its use in certain COVID-19 patients.
Hyperbaric oxygen treatment may be a feasible option for treating advanced stages of COVID-19 by reducing inflammation, promoting healing, decreasing edema, and increasing blood flow. It can also aid in the recovery of immunological and circulatory processes and stress levels. Some studies have reported improved survival in COVID-19 patients treated with HBOT.
While the therapeutic use of HBO2 in COVID-19 has been modest, interest is growing, and it shows promise as a potential treatment, especially for severe cases and hypoxemia, by improving oxygen saturation and aiding in recovery processes.
1. COVID-19 emergence date: The text states COVID-19 emerged in late December 2019. This is consistent with the timeline of the pandemic's initial identification.
2. Oxygen delivery in HBOT: The text claims that at high atmospheric pressure, oxygen inhalation absorbs fifteen times more oxygen into the plasma than the typical amount. This is a common explanation for HBOT's efficacy.
3. COVID-19 variants: The text lists several variants: alpha, beta, gamma, delta, and epsilon. These are recognized SARS-CoV-2 variants of concern.
Loading PDF...
Loading Statistics...